Koistinen HA - Search Results

1

The effects of acute hyperinsulinemia on bone metabolism.

Ivaska KK, Heliövaara MK, Ebeling P, Bucci M, Huovinen V, Väänänen HK, Nuutila P, Koistinen HA. Ivaska KK, et al. Among authors: koistinen ha. Endocr Connect. 2015 Sep;4(3):155-62. doi: 10.1530/EC-15-0022. Epub 2015 Jun 5. Endocr Connect. 2015. PMID: 26047829 Free PMC article.

2

Insulin-independent glucose transport regulates insulin sensitivity.

Ebeling P, Koistinen HA, Koivisto VA. Ebeling P, et al. Among authors: koistinen ha. FEBS Lett. 1998 Oct 9;436(3):301-3. doi: 10.1016/s0014-5793(98)01149-1. FEBS Lett. 1998. PMID: 9801136 Free article. Review.

3

Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes.

Ebeling P, Teppo AM, Koistinen HA, Koivisto VA. Ebeling P, et al. Among authors: koistinen ha. Metabolism. 2001 Mar;50(3):283-7. doi: 10.1053/meta.2001.21032. Metabolism. 2001. PMID: 11230779 Clinical Trial.

4

Paradoxical rise in serum adiponectin concentration in the face of acid-induced insulin resistance 13-cis-retinoic.

Koistinen HA, Remitz A, Koivisto VA, Ebeling P. Koistinen HA, et al. Diabetologia. 2006 Feb;49(2):383-6. doi: 10.1007/s00125-005-0089-z. Epub 2005 Dec 28. Diabetologia. 2006. PMID: 16380803 Clinical Trial.

5

Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes.

Ebeling P, Teppo AM, Koistinen HA, Viikari J, Rönnemaa T, Nissén M, Bergkulla S, Salmela P, Saltevo J, Koivisto VA. Ebeling P, et al. Among authors: koistinen ha. Diabetologia. 1999 Dec;42(12):1433-8. doi: 10.1007/s001250051315. Diabetologia. 1999. PMID: 10651262 Clinical Trial.

6

The effect of exercise on leptin concentration in healthy men and in type 1 diabetic patients.

Koistinen HA, Tuominen JA, Ebeling P, Heiman ML, Stephens TW, Koivisto VA. Koistinen HA, et al. Med Sci Sports Exerc. 1998 Jun;30(6):805-10. doi: 10.1097/00005768-199806000-00005. Med Sci Sports Exerc. 1998. PMID: 9624635

7

Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects.

Koistinen HA, Dusserre E, Ebeling P, Vallier P, Koivisto VA, Vidal H. Koistinen HA, et al. Diabetes Metab Res Rev. 2000 Sep-Oct;16(5):364-9. doi: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr148>3.0.co;2-c. Diabetes Metab Res Rev. 2000. PMID: 11025560

8

Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid.

Koistinen HA, Remitz A, Gylling H, Miettinen TA, Koivisto VA, Ebeling P. Koistinen HA, et al. Diabetes Metab Res Rev. 2001 Sep-Oct;17(5):391-5. doi: 10.1002/dmrr.222. Diabetes Metab Res Rev. 2001. PMID: 11747145

9

Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men.

Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA, Ebeling P. Koistinen HA, et al. Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):1034-9. doi: 10.1161/01.atv.21.6.1034. Arterioscler Thromb Vasc Biol. 2001. PMID: 11397716

10

Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects.

Koistinen HA, Bastard JP, Dusserre E, Ebeling P, Zegari N, Andreelli F, Jardel C, Donner M, Meyer L, Moulin P, Hainque B, Riou JP, Laville M, Koivisto VA, Vidal H. Koistinen HA, et al. Eur J Clin Invest. 2000 Apr;30(4):302-10. doi: 10.1046/j.1365-2362.2000.00625.x. Eur J Clin Invest. 2000. PMID: 10759878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters